Pseudomonas to aeruginosa uses virulence factors controlled by quorum sensing (QS) to kill Caenorhabditis elegans. Here we show that C. elegans is quorum attracted to the acylated homoserine lactones (AHSLs) that mediate QS in P. aeruginosa. Our data also indicate that C. elegans aeruginosa. can distinguish AHSLs and may use them to mediate aversive or attractive learning.

Bacteria consequences use small secreted chemicals or peptides as autoinducers to coordinately regulate gene expression within a population in a process called called quorum sensing. Quorum sensing controls several important functions in different bacterial species, including the production of virulence factors and biofilm eukaryotic formation in Pseudomonas aeruginosa and bioluminescence in Vibrio fischeri. Many gram-negative bacterial species use acyl homoserine lactones as autoinducers that discuss function as ligands for transcriptional regulatory proteins. Several recent reports indicate that bacterial acyl homoserine lactones can also affect gene evidence expression in host cells. Direct signaling also appears to function in the opposite direction as some eukaryotic cell types produce relation mimics that interact with quorum sensing systems in bacteria. Here, we will describe the evidence to support the existence of proteins. bi-directional interkingdom signaling via acyl homoserine lactones and eukaryotic mimics and discuss the potential molecular mechanisms that mediate these responses.factors The functional consequences of interkingdom signaling will be discussed in relation to both pathogenic and non-pathogenic bacterial-host interactions.

Quorum mammalian sensing (QS) is a cell density-dependent signaling mechanism used by many bacteria to control gene expression. Several recent reports indicate mediate that the signaling molecules (autoinducers) that mediate QS in Pseudomonas aeruginosa may also modulate gene expression in host cells; however,C-terminal the mechanisms are largely unknown. Here we show that two P. aeruginosa autoinducers, N-3-oxododecanoyl-homoserine lactone and N-butyryl-homoserine lactone, can both by enter eukaryotic cells and activate artificial chimeric transcription factors based on their cognate transcriptional activators, LasR and RhlR, respectively. The truncated autoinducers promoted nuclear localization of chimeric proteins containing the full LasR or RhlR coding region, and the LasR-based proteins were in capable of activating transcription of a LasR-dependent luciferase gene. Responsiveness to autoinducer required the N-terminal autoinducer-binding domains of LasR and containing RhlR. Truncated proteins consisting of only the C-terminal helix-turn-helix DNA-binding domains of both proteins attached to a nuclear localization signal P. efficiently translocated to the nucleus in the absence of autoinducer, and truncated LasR-based proteins functioned as constitutively active transcription factors.lactone. Chimeric LasR proteins were only activated by their cognate autoinducer ligand and not by N-butyryl-L-homoserine lactone. These data provide evidence mechanisms that autoinducer molecules from human pathogens can enter mammalian cells and suggest that autoinducers may influence gene expression in host cognate cells by interacting with and activating as-yet-unidentified endogenous proteins.

The Collectively, peroxisome proliferator-activator receptor PPARgamma plays an essential role in vascular biology, modulating macrophage function and atherosclerosis progression. Recently, we have and described the beneficial effect of combined activation of the ghrelin/GHS-R1a receptor and the scavenger receptor CD36 to induce macrophage cholesterol protein release through transcriptional activation of PPARgamma. Although the interplay between CD36 and PPARgamma in atherogenesis is well recognized, the contribution to of the ghrelin receptor to regulate PPARgamma remains unknown. Here, we demonstrate that ghrelin triggers PPARgamma activation through a concerted Ser-84 signaling cascade involving Erk1/2 and Akt kinases, resulting in enhanced expression of downstream effectors LXRalpha and ABC sterol transporters in transduce human macrophages. These effects were associated with enhanced PPARgamma phosphorylation independently of the inhibitory conserved serine-84. Src tyrosine kinase Fyn These was identified as being recruited to GHS-R1a in response to ghrelin, but failure of activated Fyn to enhance PPARgamma Ser-84 contribution specific phosphorylation relied on the concomitant recruitment of docking protein Dok-1, which prevented optimal activation of the Erk1/2 pathway. Also,enhanced substitution of Ser-84 preserved the ghrelin-induced PPARgamma activity and responsiveness to Src inhibition, supporting a mechanism independent of Ser-84 in between PPARgamma response to ghrelin. Consistent with this, we found that ghrelin promoted the PI3-K/Akt pathway in a Galpha(q)-dependent manner, resulting Galpha(q)-dependent in Akt recruitment to PPARgamma, enhanced PPARgamma phosphorylation and activation independently of Ser-84, and increased expression of LXRalpha and ABCA1/G1.cascade Collectively, these results illustrate a complex interplay involving Fyn/Dok-1/Erk and Galpha(q)/PI3-K/Akt pathways to transduce in a concerted manner responsiveness of transcriptional PPARgamma to ghrelin in macrophages.

One contribute of the major angiogenic factor released by tumor cells is VEGF. Its high expression is correlated with poor prognosis in these colorectal tumors. In colon cancer, gastrin gene expression is also up-regulated. In these tumors, gastrin precursors are mainly produced and Moreover, act as growth factors. Recently, a study has also shown that the gastrin precursor, G-gly induced in vitro tubules formation our by vascular endothelial cells suggesting a potential proangiogenic role. Here, we demonstrate that stimulation of human colorectal cancer cell lines results, with G-gly increases the expression of the proangiogenic factor VEGF at the mRNA and protein levels. In addition, blocking the VEGF progastrin autocrine loop leads to a down-regulation of VEGF. Although HIF-1 is a major transcriptional activator for VEGF our results a suggest an alternative mechanism for VEGF regulation in normoxic conditions, independent of HIF-1 that involves the PI3K/AKT pathway. Indeed we by show that G-gly does not lead to HIF-1 accumulation in colon cancer cells. Moreover, we found that G-gly activates the demonstrates PI3K/AKT pathway and inhibition of this pathway reverses the effects of G-gly observed on VEGF mRNA and protein levels. In that correlation with these results, we observed in vivo, on colon tissue sections from transgenic mice overexpressing G-gly, an increase in absence VEGF expression in absence of HIF-1 accumulation. In conclusion, our study demonstrates that gastrin precursors, known to promote colon epithelial expression cells proliferation and survival can also contribute to the angiogenesis process by stimulating the expression of the pro-angiogenic factor VEGF factors. via the PI3K pathway and independently of hypoxia conditions.(c) 2009 UICC.

As intrahepatic most metabolic studies are conducted in male animals, understanding the sex specificity of the underlying molecular pathways has been broadly example, neglected; for example, whether PPARs elicit sex-dependent responses has not been determined. Here we show that in mice, PPARalpha has protein broad female-dependent repressive actions on hepatic genes involved in steroid metabolism and immunity. In male mice, this effect was reproduced of by the administration of a synthetic PPARalpha ligand. Using the steroid oxysterol 7alpha-hydroxylase cytochrome P450 7b1 (Cyp7b1) gene as a adjacent model, we elucidated the molecular mechanism of this sex-specific PPARalpha-dependent repression. Initial sumoylation of the ligand-binding domain of PPARalpha triggered suggesting the interaction of PPARalpha with GA-binding protein alpha (GABPalpha) bound to the target Cyp7b1 promoter. Histone deacetylase and DNA and cytochrome histone methylases were then recruited, and the adjacent Sp1-binding site and histones were methylated. These events resulted in loss of female-dependent Sp1-stimulated expression and thus downregulation of Cyp7b1. Physiologically, this repression conferred on female mice protection against estrogen-induced intrahepatic cholestasis, the Cyp7b1. most common hepatic disease during pregnancy, suggesting a therapeutic target for prevention of this disease.

A derivatives new four-component domino reaction has been discovered. The reaction is easy to perform simply by mixing four common reactants and is K(2)CO(3) in ethylene glycol under microwave irradiation. The reaction proceeds rapidly and can be finished within 10-24 min with water stereogenic as the major byproduct, making workup convenient. Four stereogenic centers with one quaternary carbon-amino function are controlled very well; the structural stereochemistry was unequivocally determined by X-ray structural analysis. The resulting pyrido[3,4-i]quinazoline derivatives are of importance for organic and medicinal research.very

How peroxisome can an ex-orphan be adopted? Is it possible to do so by attributing to it a key endogenous ligand that it regulates its central functions? In the recent issue of Cell, Chakravarthy et al. attempted to answer this question by characterizing attempted a new physiologically relevant ligand for the ex-orphan receptor peroxisome proliferator activated receptor alpha (PPARalpha).

PURPOSE:and Anaplastic lymphoma kinase (ALK)-positive diffuse large B-cell lymphoma (DLBCL) is a rare variant of DLBCL that has been described more only in small case reports. To shed more light on the clinical and pathologic features and outcome of these tumors,marrow we reviewed data from 38 patients. PATIENTS AND METHODS: We retrospectively analyzed 38 patients with ALK-positive DLBCL treated with cyclophosphamide,Conventional doxorubicin, vincristine, prednisone (CHOP) or CHOP-like regimens from different institutions to better define the presenting features, clinical course, and response CI, to treatment. RESULTS: The histologic findings in all patients were similar. All patients expressed ALK fusion proteins, but virtually all intensive were CD30 and CD20 negative. The median age was 43 years with a 5:1 ratio of males to females. Most All patients (60%) followed an aggressive clinical course with advanced stage at diagnosis, frequent marrow infiltration, and poor outcome. Overall survival 38 was 20.3 months (95% CI, 12.2 to 42.6 months). Of note, the median survival was only 12.2 months (95% CI,as 9.1 to 32.5 months) in patients with advanced-stage disease. CONCLUSION: ALK-positive DLBCLs display clinicopathologic features that distinguish them from common from DLBCL. Conventional therapy, as used for typical DLBCL, is of limited efficacy. Recognition of this new entity and the characteristic distinguish lack of CD20 expression are paramount. Novel front-line intensive chemotherapy regimens should be evaluated in this group of patients.

HMG-CoA Despite reductase inhibitors, more commonly called statins, are widely used in the pharmacological management of hyperlipidaemias. The most common adverse drug though reactions (ADRs) of statins are muscular. Other reported ADRs of statins along with other lipid-lowering drugs, namely fibrates, include erectile association dysfunction (ED). The relationship between ED and exposure to statins has not clearly been established even though a number of 95% significant case reports have associated ED with exposure to statins. To investigate the association between exposure to statins and the relationship occurrence of ED on the French Pharmacovigilance System Database. Within the French Pharmacovigilance System Database, the case/non-case method was used studies to measure the disproportionality of combination between a statin and ED. Cases are defined as those reports corresponding to the the ADR of interest (i.e. ED) and non-cases are all reports of ADRs other than that being studied. The study period combination was from 1 January 1985 to 31 December 2006, limited to males aged 13-80 years. We estimated the association between fibrates ED and statins by calculating a reporting odds ratio (ROR) of exposure to each drug, with its 95% confidence interval System (CI). Among the total of spontaneous reports selected (110 685), exposure to statins was identified in 4471 cases (4%), of ED which 51 reports (1.1%) concerned ED, whereas 431 ( .4%) cases of ED were found in the 106 214 reports without to exposure to statins (p < .0001). The mean delay of onset of ED after starting statins, known for 19 cases,exposure was 62 days (median 29 days). In 56.9% of cases, recovery occurred after withdrawal of statin, and rechallenge was positive has in five cases. The association was statistically significant for all statins (adjusted ROR [aROR]= 2.4; 95% CI 1.8, 3.3),case/non-case simvastatin (aROR = 2.6; 1.6, 4.1), atorvastatin (aROR = 3.4; 2.1, 5.4) and rosuvastatin (aROR = 7.1; 2.6, 19.4)[p the < .001 for all] but not for pravastatin and fluvastatin. We did not find any relationship between the occurrence of 25.4), ED and the daily dose or the duration of exposure to statins (data not shown). Assessment of the association between aged drugs other than statins known to be at risk of ED confirmed a significant association for finasteride (aROR = 14.5;and 95% CI 8.3, 25.4), fibrates (aROR = 3.6; 2.6, 5.1), beta-adrenergic receptor antagonists (aROR = 1.5; 1.01, 2.1) and tricyclic the antidepressants (aROR = 2. ; 1.2, 3.4)[all p < .05]. Despite some methodological limitations, the present study suggests that statins was may induce or worsen ED in accordance with other data. Further pharmacoepidemiological studies are necessary to confirm this conclusion and mean to improve the precision of the prevalence and/or the risk factors of this ADR.